$DSGN
Design Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$11.69
▼-2.34%-$0.280
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateDesign Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is DSGN down today? It is at $11.69 (-2.34%), and our scanner flagged it 65 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DSGN spikes, and full due diligence on DSGN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $DSGN 65 times in the last 30 days. Create a free account to track $DSGN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on DSGN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DSGN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
William Arsani Director | Sold (automatic/other) | -563K 0.9% of company | sold 13% | 3.65M | $3.0M at $5.25 | Aug 13, 25 |
Prasad Deepa Director | Sold (automatic/other) | -4K | sold 16% | 20K | $24K at $6.27 | Dec 18, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on DSGN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DSGN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
DSGN last traded at $11.69, down 2.34% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Design Therapeutics, Inc. Common Stock (DSGN) is next expected to report earnings on Wednesday, November 4, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The DSGN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DSGN 65 times in the last 30 days.
DSGN (Design Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $732M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DSGN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$DSGN discussion
Sign in to ask a question or join the discussion.